VERFOO BRIGHTENING HYDRATING ANTIWRINKLE SUNSCREEN- titanium dioxide, octinoxate cream

VERFOO Brightening Hydrating Antiwrinkle Sunscreen by

Drug Labeling and Warnings

VERFOO Brightening Hydrating Antiwrinkle Sunscreen by is a Otc medication manufactured, distributed, or labeled by LCM TECHNOLOGY Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Ethylhexyl Methoxycinnamate (Octinoxate) 7.5%
Titanium Dioxide (Nano) 1.35%

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children

PURPOSE

sunscreen

INDICATIONS & USAGE

Apply 15 minutes before sun exposure.
Reapply at least every 2 hours.
Children under 6 months of age: ask a doctor.
Apply generously and evenly to face and exposed areas of the body.

DOSAGE & ADMINISTRATION

Helps prevent sunburn.
Decreases the risk of skin cancer and early skin aging caused by the sun.

WARNINGS

For external use only.
Do not use on damaged or broken skin.
When using this product, keep out of eyes. Rinse with water to remove.
Stop using and consult a doctor if rash or irritation occurs.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

INACTIVE INGREDIENT

Water, Ethylhexyl, Methoxycinnamate, Isododecane, Butylene Glycol, Cyclopentasiloxane, Niacinamide, Ethylhexyl, Salicylate, Silica, Methylene Bis-Benzotriazolyl Tetramethylbutylphenol, Ethylhexyl Triazone, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Ethylhexyl Dimethyl PABA, Bis-Ethylhexyloxypenol Methoxyphenyl Triazine, Potassium Cetyl Phosphate, Sodium Chloride, Diethylhexyl Carbonate, Butyloctyl Sulfate, Trimethylsiloxysilicate, Pentaerythrityl Tetraethylhexanoate, Glycerin, Squalane, Bisabolol, Sodium Chloride, Phenoxyethanol, Polysorbate, Sodium Benzoate.

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

VERFOO BRIGHTENING HYDRATING ANTIWRINKLE SUNSCREEN 
titanium dioxide, octinoxate cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 87489-001
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	1.35 g  in 100 g
ETHYLHEXYL METHOXYCINNAMATE (UNII: 4Y5P7MUD51) (ETHYLHEXYL METHOXYCINNAMATE - UNII:4Y5P7MUD51)	ETHYLHEXYL METHOXYCINNAMATE	7.5 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
ETHYLHEXYL DIMETHYL PABA (UNII: Z11006CMUZ)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
NIACINAMIDE (UNII: 25X51I8RD4)
POTASSIUM CETYL PHOSPHATE (UNII: 03KCY6P7UT)
ISODODECANE (UNII: A8289P68Y2)
ETHYLHEXYL SALICYLATE (UNII: 4X49Y0596W)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
CYCLOPENTASILOXANE (UNII: 0THT5PCI0R)
PENTAERYTHRITYL TETRAETHYLHEXANOATE (UNII: XJ7052W897)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
WATER (UNII: 059QF0KO0R)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
METHYLENE BIS-BENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL (UNII: 8NT850T0YS)
ETHYLHEXYL TRIAZONE (UNII: XQN8R9SAK4)
DIETHYLHEXYL CARBONATE (UNII: YCD50O0Z6L)
GLYCERIN (UNII: PDC6A3C0OX)
SQUALANE (UNII: GW89575KF9)
BISABOLOL (UNII: 24WE03BX2T)
SODIUM BENZOATE (UNII: OJ245FE5EU)
TRIMETHYLSILOXYSILICATE (M/Q 0.66) (UNII: 5041RX63GN)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 87489-001-02	1 in 1 BOX	03/11/2026
1	NDC: 87489-001-01	40 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	03/11/2026

Labeler - LCM TECHNOLOGY Co., Ltd (696569497)

Establishment
Name	Address	ID/FEI	Business Operations
LCM TECHNOLOGY Co., Ltd		696569497	manufacture(87489-001)